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Background and purpose   Resurfacing of the patella during pri-
mary total knee arthroplasty (TKA) is often recommended based 
on higher revision rates in non-resurfaced knees. As many of these 
revisions are insertions of a patella component due to pain, and 
since only patients with a non-resurfaced patella have the option 
of secondary resurfacing, we do not really know whether these 
patients have more pain and poorer function. The main purpose 
of the present paper was therefore to assess pain and function at 
least 2 years after surgery for unrevised primary non-resurfaced 
and resurfaced TKA, and secondary among prosthesis brands.
Methods   Information needed to calculate subscales from the 
knee injury and osteoarthritis outcome score (KOOS) was col-
lected in a questionnaire given to 972 osteoarthritis patients with 
intact primary TKAs that had been reported to the Norwegian 
Arthroplasty  Register.  Pain  and  satisfaction  on  visual  analog 
scales and improvement in EQ-5D index score (ΔEQ-5D) were 
also used as outcomes. Outcomes were measured on a scale from 
0 to 100 units (worst to best). To estimate differences in mean 
scores, we used multiple linear regression with adjustment for 
possible confounders.
Results   We did not observe any differences between resurfac-
ing and non-resurfacing in any outcome, with estimated differ-
ences of ≤ 1.4 units and p-values of > 0.4. There was, however, a 
tendency of better results for the NexGen implant as compared 
to the reference brand AGC for symptoms (difference = 4.9, p = 
0.05), pain (VAS) (difference = 8.3, p = 0.004), and satisfaction 
(VAS) (difference = 7.9, p = 0.02). However, none of these differ-
ences reached the stated level of minimal perceptible clinical dif-
ference.
Interpretation   Resurfacing of the patella has no clinical effect 
on pain and function after TKA. Differences between the brands 
investigated were small and they were assumed to be of minor 
importance.

There is an ongoing discussion regarding whether resurfac-
ing  of  the  patella  during  primary  total  knee  arthroplasty 
(TKA) should be recommended or not. This has led to sev-
eral observational and randomized studies, and eventually to 
meta-analyses (Forster 2004, Nizard et al. 2005, Pakos et al. 
2005, Parvizi et al. 2005). The meta-analyses have included 
studies in which the main outcomes were risk of reoperation, 
level of anterior knee pain, and other knee scores. None of 
these reviews found firm evidence regarding superiority of 
resurfaced or non-resurfaced prostheses. However, these stud-
ies still reported indications of better results for resurfaced 
prostheses, mainly because of a lower risk of reoperation for 
resurfaced implants. A critical appraisal of available evidence 
found methodological limitations in all the studies examined 
and neither treatment option was clearly superior (Calvisi et 
al. 2009).
A  previous  observational  study  from  the  Norwegian 
Arthroplasty Register (NAR) found a 1.3 times higher but not 
statistically significantly elevated (p = 0.2) overall rate of revi-
sions for non-resurfaced prostheses (Furnes et al. 2002). There 
was, however, a significantly (2.5-fold) higher rate of revision 
for infection in knees with resurfaced prostheses, while non-
resurfaced prostheses had a 5.7-times higher risk of revision 
because of pain. Many of the revisions for pain involved addi-
tion of a patella component to the native patella. Since second-
ary resurfacing is an available option only in non-resurfaced 
knees, we do not really know whether there were any differ-
ences in perception of pain between the two treatment groups. 
Further investigation of patients’ subjective pain and function 
would therefore be of value when assessing the quality of the 
two types of TKA.
The major goal of the present study was therefore to inves-
tigate whether the levels of function and pain are different for 
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prostheses, and our secondary aim was to investigate whether 
function and pain vary with different prosthesis brands.
Patients and methods
The Norwegian Arthroplasty Register (NAR)
Practically all patients (99%) who receive a primary arthro-
plasty of the knee are reported to NAR (Espehaug et al. 2006). 
The register was established in 1987 as a hip prosthesis regis-
ter, but from 1994 it was extended to cover all artificial joints 
including knee arthroplasty (Havelin et al. 2000, Furnes et al. 
2002). NAR receives information directly from the orthopedic 
surgeons. Information on patient-related outcome such as pain 
and function is not reported to the register. To assess patients’ 
perception of pain and function after undergoing TKA, we 
therefore invited selected individuals registered in the NAR to 
participate in a postal survey.
Participants
Possible participants were patients registered in the NAR with 
at least 1 unrevised cemented primary TKA inserted due to 
gonarthrosis. The individuals should be aged 85 years or less, 
and the operation should have been performed at least 2 years 
prior to the survey to ensure that the result of the intervention 
had stabilized (Murray and Frost 1998, Burnett et al. 2004, 
Lingard et al. 2004). Only patients with a prosthesis brand 
already registered with at least 100 resurfaced and 100 non-
resurfaced implants were eligible for inclusion. All patients 
with a resurfaced implant meeting these criteria were invited 
to participate in the study (134 with AGC, 186 with Genesis I, 
238 with LCS, and 112 with NexGen). Since the use of non-
resurfaced prostheses has increased and the use of resurfaced 
prostheses has decreased over the years in Norway, the selec-
tion of patients with non-resurfaced prostheses was matched 
according to brand and year of operation to ensure compat-
ibility (134 AGC, 180 Genesis I, 238 LCS, and 62 NexGen). 
It was not possible to match all resurfaced NexGen prostheses 
with  corresponding  non-resurfaced  prostheses  since  resur-
faced prostheses were almost exclusively used early in the 
period. This led to similar numbers of patients with resurfaced 
(n = 670) and non-resurfaced (n = 614) prostheses, making a 
total of 1,284 individuals. A detailed account of the selection 
procedure is given in Figure 1. 
After 2 months, a reminder was sent out to those who failed 
to  respond  to  the  initial  questionnaire.  In  all,  972  patients 
completed the questionnaire, 305 either declined or did not 
respond, and 7 patients had died or were unable to be located 
by the post office.
Questionnaire
The  questionnaire  consisted  of  the  valid  and  reliable  self-
administrated  instrument  for  calculation  of  the  knee-spe-
cific knee injury and osteoarthritis outcome score (KOOS) 
(Roos and Lohmander 2003). A Norwegian translation from 
the Swedish version of KOOS was made for this study, and 
has been approved as the official Norwegian translation. A 
description of the validation process of this translation can be 
found at www.koos.nu.
To assess the potential effect of general health factors, the 
questionnaire also included questions needed to calculate the 
Charnley category applied to knee arthroplasty patients and 
the valid and reliable instrument for health quality measure-
ment, the EQ-5D index score (Greiner et al. 2003). Informa-
tion needed for calculation of preoperative and current EQ-
5D index scores was given by the patients at the time when 
filling in the form. In addition, questions regarding patients’ 
“satisfaction with the surgery”, and degree of “pain from 
the operated knee” were included. With the exception of the 
latter two, where a visual analog scale (VAS) was used, all 
Figure 1. Description of the selection procedure. 
a For patients with bilateral intact primary prostheses, only the most 
recent with gonarthrosis as diagnosis was eligible for inclusion.
b Genesis I, AGC, LCS and NexGen were eligible for inclusion.
c Resurfaced and non-resurfaced prostheses were matched for brand 
and year of operation. This led to exclusion of 2,950 patients with 
non-resurfaced implants.
Patients in NAR that
had undergone
knee arthroplasty
2007-07-02
n = 22,466
n = 21,041
n = 15,379
n = 13,277
n = 13,236
n = 11,036
No intact primary prosthesis
n = 1,425
PATIENTS EXCLUDED
Prosthesis not fixated with cement in
femur and tibia. n = 2,102
Deceased patients
n = 961
Less than 2 years since operation
n = 3,116
Patients having a prosthesis brand 
registered with less than 100 resurfaced and/
 or 100 non-resurfaced implants. n = 2,625
 
Patient 86 years or older at start of study
n = 2,200
Prosthesis not registered with equal brand
names in all components. n = 41
Unicondylar prosthesis
n = 2,256
Diagnosis other than gonarthrosis
n = 3,406
n = 6,859
n = 4,234 b
All eligible
patients having
resurfaced
prostheses
n = 670
Group matched for
brand and year 
of operation c
Patients having
non-resurfaced
prostheses
n = 614
n = 10,075
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questions had standardized answer options given as Likert 
boxes. 
The study was approved by the Norwegian Data Inspector-
ate, Norwegian Social Science Data Services, and the Regional 
Committee for Research Ethics in Western Norway (date of 
issue: 02/23/2006, registration number: 046.06). The patients 
received the questionnaire together with an information letter, 
and returned the questionnaire to the register with a signed 
consent to participate in the study.
Outcome measures
KOOS, which was used as primary outcome on patients’ per-
ception of pain and function, consists of 42 individual ques-
tions, making up 5 subscales: Pain, other symptoms (Symp-
toms), activities in daily living (ADL), function in sport and 
recreation (Sport&Rec) and knee-related quality of life (QOL). 
Only the previous week was to be considered when answer-
ing most of the questions, and each question received a score 
from 0 to 4. A normalized score (100 indicating no symptoms 
and 0 indicating extreme symptoms) was calculated for each 
subscale. Calculation of the scores and treatment of missing 
data were done in accordance with the description at www.
koos.nu. 
In  addition,  we  used  “pain  from  the  operated  knee” 
(Pain(VAS)) and “satisfaction with the operation” (Satisfac-
tion (VAS)) as outcomes. In the analyses the VAS scores were 
reversed, with 100 indicating the best possible state and 0 indi-
cating the worst possible state. Finally, improvement in qual-
ity of life (ΔEQ-5D), calculated as the difference between the 
present and preoperative EQ-5D index scores multiplied by 
100, was used as outcome.
Sensitivity analysis of potential bias due to different 
revision criteria from resurfaced and non-resurfaced 
implants
A bias may have been introduced if a non-resurfaced prosthe-
sis was more likely to be revised than resurfaced (Australian 
Orthopaedic Association National Joint Replacement Regis-
try. Annual Report. 2008, Furnes et al. 2002). This would have 
given a falsely low proportion of patients with poor results 
in that group. The potential effect of this was assessed in a 
sensitivity analysis where we included information also from 
patients with revised prostheses. This was possible due to the 
availability of information from another survey comprising all 
patients registered in the NAR with revised implants. 
The original study material consisted of all intact resurfaced 
knees in the register that met the inclusion criteria, and about 
the same number of intact non-resurfaced knees matched on 
year of operation. To these we added all revised resurfaced 
knees that met the inclusion criteria (n = 23) and varying 
numbers of revised non-resurfaced implants. The latter were 
randomly selected from the 148 revised non-resurfaced knees 
that met the inclusion criteria. The Mann-Whitney test was 
used  to  compare  pain  and  discomfort  between  the  groups 
using the specific EQ-5D question regarding pain and discom-
fort (1 = best, 3 = worst). This information related to when the 
questionnaire was filled in for patients with intact prostheses, 
while patients with a revised prosthesis gave information in 
retrospect regarding their situation before the revision.
Statistics
Minimal  perceptible  clinical  difference  is  8–10  units  for 
KOOS  subscales  (Roos  and  Lohmander  2003)  and  9–12 
units on a visual analog scale (Ehrich et al. 2000). To have 
an 80% chance of detecting a significant (at the 2-sided 5% 
level) 10-point difference between the 2 groups in the mean 
KOOS subscales, with an assumed standard deviation of 20, 
64 individuals in each treatment group were required. Thus, 
to ensure good representation for both treatment groups, a 
restriction on operation volume of each brand was set to at 
least 100 registered resurfaced and 100 registered non-resur-
faced operations. 
Differences  in  response  rates  were  tested  with  the  chi-
squared-test. To estimate differences in mean outcome scores 
for non-resurfaced and resurfaced prostheses, we used multi-
ple linear regression with adjustment for possible confounding 
by age (< 65, 65–70, 70–80, > 80), sex, preoperative EQ-5D 
index score (< 30, 0.30–0.69, > 0.69), Charnley category (A, 
B, C), and brand of prosthesis. We also investigated any dif-
ferences within a particular prosthesis brand. Adjusted differ-
ences in mean values between resurfaced and non-resurfaced 
prostheses are presented with 95% confidence intervals (95% 
CIs) and p-values. 
Multiple linear regression was also used to investigate any 
possible association between prosthesis brand and mean out-
come scores. In these analyses, we also adjusted for time since 
operation. Adjusted differences in mean scores are presented 
with p-values relative to the AGC prosthesis brand. 9 patients 
who did not have the AGC Universal design were excluded 
from this analysis (5 resurfaced and 4 non-resurfaced).
In addition, all analyses were performed excluding prosthe-
ses with posterior cruciate ligament sacrificing design and also 
excluding constrained condylar prostheses (18 prostheses: 10 
resurfaced and 8 non-resurfaced).
In the analyses, p-values less than 0.05 were considered 
statistically significant. The analyses were performed using 
SPSS statistical software version 15.0.0.1.
Results
We  received  completed  questionnaires  from  972  (76%)  of 
the 1,284 individuals selected for the study. Thus, the study 
included 504 knees with resurfaced TKA and 468 knees with 
non-resurfaced TKA. The response rate was similar for non-
resurfaced prostheses (76%) and resurfaced prostheses (75%) 
(p = 0.7), but it was lower for female patients (73%) than for 
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patients: 88% for those less than 65 years of age and 67% 
for those older than 80 (p < 0.001). Response rates for each 
brand of prosthesis varied between 71% and 79% (Table 1, 
see Supplementary data). Male patients constituted 29% of 
the material and the mean age at the time of completing the 
questionnaire was 76 (SD 8) years. Table 2 gives the distribu-
tion of patient characteristics by prosthesis type and prosthesis 
brand. 
We observed no differences between resurfaced and non-
resurfaced prostheses for any of the eight outcomes, with all 
p-values > 0.4 (Table 3 and Figure 2); nor did we find evidence 
of any differences between the 2 treatment options when anal-
yses were performed within each brand of prosthesis (Genesis 
I, AGC, LCS, and NexGen) (Table 3 and Figure 3).
Since non-resurfaced and resurfaced prostheses generally 
showed similar results, we did not differentiate between the 
two treatment groups when investigating possible effects on 
pain and function of prosthesis brand, sex, age, Charnley Cat-
egory, time since operation, and preoperative EQ-5D index 
score (Table 4) (Figure 4, see Supplementary data). Genesis 
I and LCS did not perform statistically significantly different 
from the reference brand AGC, but there was a tendency of 
Table 2. Patient characteristics by prosthesis type and prosthesis brand
  AGC  Genesis I  LCS  NexGen  Total
No. of prostheses
  Resurfaced    99  132  184    89  504
  Non-resurfaced  106  134  180    48  468
  All  205  266  364  137  972
No. of hospitals
  Resurfaced    16    18      9      3    40
  Non-resurfaced    12    21    19      7    47
  All            56
Men %
  Resurfaced    32   25    32    29    30
  Non-resurfaced    32   29    24    40    29
  All            29
Mean (SD) age (years) a
  Resurfaced  76 (7.2)  77 (7.1)  75 (8.1)  74 (8.1)  76 (7.7)
  Non-resurfaced  76 (8.6)  78 (6.0)  76 (7.6)  74 (9.3)  76 (7.7)
  All          76 (7.7)
Mean (SD) time since operation (years) b
  Resurfaced  7.2 (2.5)  9.2 (1.7)  6.5 (1.8)  5.2 (1.9)  7.1 (2.4)
  Non-resurfaced  7.1 (2.4)  9.2 (1.6)  6.5 (1.8)  3.6 (0.9)  7.1 (2.5)
All          7.1 (2.4)
Charnley Category C %
  Resurfaced    57    69    61    66    63
  Non-resurfaced    66    65    69    61    66
  All            65
Mean (SD) preoperativ EQ-5D index score
  Resurfaced  0.48 (0.23)  0.47 (0.22)  0.44 (0.23)  0.45 (0.23)  0.46 (0.23)
  Non-resurfaced  0.47 (0.20)  0.46 (0.22)  0.48 (0.23)  0.43 (0.20)  0.47 (0.22)
  All          0.46 (0.22)
a Mean age when completing the questionnaire.
b Mean time since operation when completing the questionnaire.
Table 3. Mean difference a in outcome between resurfaced and non-resurfaced prostheses
Prosthesis  Pain  Symptoms  ADL  Sport&Rec  QOL  Pain(VAS)  Satisfaction(VAS)   ΔEQ-5D 
brands  Δ  p  Δ  p  Δ  p  Δ  p  Δ  p  Δ  p  Δ  p  Δ p
Total b  0.8  0.6  0.2  0.9  1.4  0.4  1.4  0.5  –0.2  0.9  -0.1  0.9  –0.7  0.7  0.4  0.9
AGC c  0.8  0.8  0.0  1.0  2.1  0.5  0.2  1.0  –1.9  0.6  –0.4  0.9  –1.2  0.7  1.4  0.8
Genesis I c  4.0  0.2  0.7  0.8  3.2  0.3  1.8  0.6  1.0  0.8  2.5  0.4  1.1  0.7  6.3  0.1
LCS c  –1.3  0.6  –0.1  1.0  0.9  0.8  2.9  0.4  1.0  0.8  –1.3  0.6  –2.5  0.4  –4.1  0.2
NexGen c  –0.6  0.9  –1.3  0.7  –4.0  0.4  –4.3  0.4  –4.3  0.4  –1.7  0.6  0.0  1.0  –1.3  0.8
                                              
a Differences (Δ) = mean scores among non-resurfaced prostheses minus mean scores among resurfaced prostheses.
b Differences in mean are adjusted for age, sex, preoperative EQ-5D index score (except for ΔEQ-5D), Charnley category and prosthesis brand.
c Differences in mean are adjusted for age, sex, preoperative EQ-5D index score (except for ΔEQ-5D)  and Charnley category.Acta Orthopaedica 2010; 81 (1): 99–107  103
poorer results for the Genesis I for all outcomes. NexGen had 
a tendency of better results than AGC, but this was only sta-
tistically significant for the outcomes Symptoms (difference = 
4.9, p = 0.05), Pain(VAS) (difference = 8.3, p = 0.004) and 
Satisfaction(VAS) (difference = 7.9, p = 0.02).
We  found  that  male  patients  performed  statistically  sig-
nificantly better than females in all outcomes except for the 
ΔEQ-5D. Charnley group A performed better than both group 
B and C for all outcomes, while there was a positive effect 
Discussion
We have studied performance of TKA based on data from 
the NAR. Using self-reported degree of pain and function as 
outcome, our analyses did not show any differences between 
resurfaced and non-resurfaced primary total knee prostheses 
2 years or more after surgery. Differences between prosthe-
Figure 3. Mean outcome scores for resurfaced and non-resurfaced prostheses, for each brand of prosthesis. The first 5 outcomes from the left 
represent the KOOS subscales. Adjustments were made for age, sex, preoperative EQ-5D index score (except for the outcome ΔEQ-5D), and 
Charnley category. Outcomes were measured on a scale from 0 to 100 units (worst to best).
Figure 2. Mean outcome scores for resurfaced and non-resurfaced prostheses. The first 
5 outcomes from the left represent the KOOS subscales. Adjustments were made for 
age, sex, preoperative EQ-5D index score (except for the outcome ΔEQ-5D), Charnley 
category, and prosthesis brand. Outcomes were measured on a scale from 0 to 100 
units (worst to best).
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of  higher  age  except  for  the  2  KOOS  sub-
scales ADL and Sport&Rec and the outcome 
Satisfaction(VAS). Improvement as measured 
by ΔEQ-5D decreased, however, with increas-
ing age (Table 4). 
Exclusion of prostheses with posterior cru-
ciate ligament sacrificing design and of con-
strained condylar prostheses gave only minor 
changes to the results above. 
Sensitivity analysis
The mean pain and discomfort score (EQ-5D) 
was 1.6 both for intact resurfaced and non-resur-
faced prostheses (original material). For resur-
faced knees, the mean score increased to 1.7 
when all revised knees (n = 23) were included. 
The mean score was also 1.7 for non-resurfaced 
knees when the same number of revised knees 
was added (Table 5). No statistically significant 
difference in mean scores was observed until 
the number of revised knees added was more 
than 3 times higher for non-resurfaced knees (n 
> 69) than for resurfaced knees (Table 5).104  Acta Orthopaedica 2010; 81 (1): 99–107
sis brands were small and did not reach 
the required level of minimal perceptible 
clinical difference relative to the refer-
ence brand, AGC. 
Strengths and limitations
The strength of our study is that use of 
data  from  a  nationwide  register  with 
almost complete coverage gives us the 
opportunity  to  include  several  implant 
designs and to involve large numbers of 
surgeons and hospitals performing vari-
ous amounts of surgery. Since this gives 
us information from a broad spectrum of 
implants,  surgical  techniques,  surgeon 
experience, and procedures, the validity 
of the results may be more global than 
that  from  randomized  controlled  trials 
(RCTs).
Despite  having  several  advantages, 
observational  studies  may  be  affected 
by  limitations  that  are  absent  in  well-
designed  RCTs.  We  have  treated  the 
most  common  confounding  factors  by 
Table 4. Effects on mean outcome of gender, age, preoperative EQ-5D index score, time since operation, Charnley category 
and prosthesis brand
  Pain  Symptoms  ADL  Sport&Rec  QOL  Pain(VAS)  Satisfaction(VAS)   ΔEQ-5D 
Risk predictors  n  Δ a  p  Δ a  p  Δ a  p  Δ a  p  Δ a  p  Δ a  p  Δ a  p  Δ a p
                                        
 Sex
  Male  284  ref    ref    ref    ref    ref    ref    ref    ref
  Female  679  –8.6  e  –6.5  e  –10.1  e  –15.5  e  –8.1  e  –6.1  e  –6.7  e  –2.9  0.2
Age (years) b
  <65   94  ref    ref    ref    ref    ref    ref    ref    ref
    65–70   108  7.1  0.05  4.3  0.1  3.5  0.3  1.2  0.8  2.7  0.5  4.0  0.2  0.9  0.8  –0.2  1.0
    70–80   396  7.9  0.01  6.3  0.01  1.9  0.5  –1.5  0.7  3.1  0.4  7.3  0.01  1.9  0.6  –4.6  0.2
  >80   365  10.9  e  10.0  e  3.5  0.3  1.8  0.6  8.4  0.02  8.5  0.004  3.0  0.4  –11.5  0.002
Preoperative EQ-5D index score c
  <0.30  286  ref    ref    ref    ref    ref    ref    ref   
    0.30–0.69  469  8.6  e  4.7  0.002  7.2  e  3.8  0.09  6.0  0.006  5.9  e  3.2  0.1
  >0.69  148  11.3  e  9.2  e  12.1  e  9.1  0.004  13.3  e  9.3  e  7.5  0.006
Years since operation  –0.5  0.2  –0.3  0.4  –0.6  0.2  0.2  0.7  –0.1  0.8  –0.1  0.9  0.2  0.8  –0.7  0.2
Charnley Category c
  A  195  ref    ref    ref    ref    ref    ref    ref    ref
  B  128  –13.1  e  –9.1  e  –11.2  e  –17.8  e  –16.8  e  –13.2  e  –8.7  0.004  –11.2  0.001
  C  585  –9.6  e  –6.6  e  –14.5  e  –15.3  e  –13.7  e  –10.6  e  –7.3  0.001  –5.9  0.02
Prosthesis brand
  AGC d   196  ref    ref    ref    ref    ref    ref    ref    ref
  Genesis I  266  –1.5  0.5  –2.9  0.2  –2.6  0.3  –3.1  0.3  –4.2  0.2  –3.2  0.2  –3.1  0.2  –0.6  0.8
  LCS  364  1.2  0.6  1.2  0.5  0.9  0.7  3.4  0.2  –0.1  1.0  1.9  0.4  0.5  0.8  1.8  0.5
  NexGen  137  5.4  0.08  4.9  0.05  4.0  0.2  3.9  0.3  6.5  0.07  8.3  0.004  7.9  0.02  5.9  0.1
a Differences in mean scores are adjusted for all other variables in a linear regression model.
b Age when completing the questionnaire.
c  Information on preoperative EQ–5D index score was not given by 60 patients and on Charnley category by 55 patients.
d  9 patients not having the AGC Universal design were excluded (5 resurfaced and 4 non-resurfaced).
e  p-value < 0.001.
Table 5. Sensitivity analysis of potential bias due to different revision criteria from 
resurfaced and non-resurfaced implants
Ratio a  Non-resurfaced  Resurfaced  Mann-Whitney
  Primary   Revised   Mean   Primary   Revised   Mean   p-value
  (n)  (n)  pain b  (n)  (n)  pain b 
– c  468  –  1.6  504  –  1.6  0.9
– d  –  145 e  2.7  –  23  2.6  0.7
1.0  468  23  1.7  504  23  1.7  1.0
1.3  468  30  1.7  504  23  1.7  0.7
1.5  468  35  1.7  504  23  1.7  0.6
2.0  468  46  1.7  504  23  1.7  0.5
2.5  468  58  1.8  504  23  1.7  0.1
3.0  468  69  1.8  504  23  1.7  0.07
3.5  468  81  1.8  504  23  1.7  0.02
a Approximate ratio between number of revised non-resurfaced and revised resurfaced 
  implants.
b Score from the EQ-5D question regarding pain and discomfort (1=best,3=worst)
c Original data; patients with unrevised implants.
d Additional data; patients with revised implants. Among the 23 revised resurfaced prosthe-
  ses the most common reasons for revision were loose distal component (n=11) and pain 
  (n=7). Among the 145 revised non-resurfaced prostheses the most common reasons for 
  revision were loose distal component (n=38), instability (n=13), deep infection (n=14) and 
  pain (n=72). More than one reason for revision may have been given.
e 3 of the 148 available patients with revised non-resurfaced implants failed to answer the 
  specific EQ-5D question.Acta Orthopaedica 2010; 81 (1): 99–107  105
using matching procedures and adjustments in the statistical 
model, but there may still have been variables that were not 
taken into account. Different criteria in the decision making by 
the surgeons might possibly lead to confounding. Imbalanced 
differences between the groups are, however, not very likely 
in Norway as most surgeons—for specific time periods—have 
used one of the two treatment options almost exclusively.
Selection bias is not very likely since the group of non-
responding individuals was acceptably small and there were 
no statistically significantly different response rates between 
the  most  important  subgroups.  It  is  difficult  to  point  out 
important factors that could have characterized the group of 
non-responding individuals and among those who were not 
eligible for inclusion, such as patients who had died. 
Bias  may,  however,  have  been  introduced  if  the  study 
included a falsely low proportion of individuals with poor 
results  among  the  non-resurfaced  patients.  This  might  be 
the  case  if  non-resurfaced  knees  were  revised  more  often 
than resurfaced knees, making such patients ineligible for 
inclusion in the study. This was investigated in a sensitivity 
analysis where information from varying numbers of revised 
prostheses were added to the original material. However, we 
observed no statistically significant difference between the 
treatment groups until more than 3 times as many revised 
non-resurfaced  prostheses  (n  >  69)  as  revised  resurfaced 
prostheses (n = 23) had been added to the material. Such a 
substantial difference is not supported by the results of large 
observational  studies  (Australian  Orthopaedic  Association 
National Joint Replacement Registry. Annual Report. 2008, 
Furnes et al. 2002), with a 30% higher rate of revision for 
non-resurfaced prostheses.
Since every outcome in our study, except the ΔEQ-5D, was 
based on the patients’ perception of pain and function expe-
rienced during the previous week, we assume that the risk of 
recall bias was negligible.
Explanations/mechanisms
Our results suggest that resurfacing of the patella has no effect 
on patients’ perception of pain and function in knees with 
unrevised implants. This is in contrast to the existing practice 
in many countries where the use of a patella component is rec-
ommended, often based on higher revision rates in non-resur-
faced prostheses. The higher revision rates with non-resur-
faced implants may, however, be due to possible overuse of 
the uniquely available option of secondary resurfacing of the 
patella if the knee is painful, and do not necessarily indicate 
poorer performance regarding pain and function.
 Estimated differences between prosthesis brands (as com-
pared to the reference brand, AGC) were small and less than 
the stipulated minimal perceptible clinical difference of 8–10 
units for KOOS subscales (Roos and Lohmander 2003) and 
9–12 units for outcomes on a visual analog scale (Ehrich et al. 
2000). The somewhat better results with the newer NexGen 
implant are interesting, but there was a limited number of 
hospitals and surgeons involved using NexGen. Less pros-
thesis wear and improved surgical techniques over the years 
may, however, explain some of the differences observed since 
mean time since operation was lower for knees with a NexGen 
implant. We have, however, adjusted for the time since opera-
tion in the statistical models. A possible positive effect of the 
search for an optimal anatomical implant during the design of 
the NexGen implant cannot be discounted.
Male patients performed better than female patients on all 
postoperative outcome measures, but we did not observe any 
gender differences in improvement based on pre- and post-
operative EQ-5D index scores (ΔEQ-5D). While the EQ-5D 
index score is not necessarily strongly related to having under-
gone TKA, this finding is in accordance with other studies 
that have shown that improvement in knee scores is similar 
for females and males after TKA (Bourne et al. 2007), but 
that women perform more poorly in preoperative scores and 
thereby  also  in  postoperative  scores  (Hawker  et  al.  2000, 
Lingard et al. 2004, Ritter et al. 2008). Some manufactur-
ers claim that newer implants specifically designed to match 
a woman’s knee will improve the results in female patients. 
This suggestion has been questioned (Ritter et al. 2008), but 
we could not investigate this issue as gender-specific implants 
were not included in this study. The observed positive effect 
of increasing age on outcomes that are strongly related to pain 
has also been seen in other studies (Elson and Brenkel 2006, 
Singh et al. 2008). Possible explanations such as higher expec-
tations of younger patients, and more activity and therefore 
increased  prosthesis  wear  have  been  suggested  (Elson  and 
Brenkel 2006). We also found that patients with unilateral 
knee disease and without comorbidity (Charnley category A) 
performed better than patients with bilateral knee disease and 
other systematic disease (Charnley category B and C). This 
supports the findings of a study based on data from the Swed-
ish Knee Arthroplasty Register (Dunbar et al. 2004) where a 
modified Charnley category was found to have a significant 
effect on outcome questionnaires after knee arthroplasty. This 
emphasizes the need to take comorbidity into account when 
performing such outcome studies.
Future research
Even though studies based on data from registers give a unique 
opportunity  to  discover  and  indicate  underlying  or  hidden 
mechanisms, their limitations underscore the need for more 
studies. Further research performed by the use of both obser-
vational studies and clinical trials is therefore needed in order 
to confirm our findings, especially since our results contradict 
with findings in previous studies (Forster 2004, Nizard et al. 
2005, Pakos et al. 2005,  Parvizi et al. 2005).
Comparison with other studies
Recent studies not included in the meta-analyses that have 
focused on outcomes other than revision rates, have differed in 
their conclusions regarding recommendation to use a patella 106  Acta Orthopaedica 2010; 81 (1): 99–107
   
 
 
 
component. 2 RCTs did not find any differences between the 2 
treatment options when the Miller-Galante II system was used 
(Campbell et al. 2006, Burnett et al. 2007). This contrasts with 
the findings on Miller-Gallante II in a previous RCT study 
(Wood et al. 2002) included in 3 meta-analyses, where resur-
facing was found to be the best choice of treatment. Another 
RCT investigating the Profix implant did not find evidence of 
any treatment option being superior to the other (Smith et al. 
2008). Neither did a recent multicenter RCT, involving 1715 
patients, observe any difference between paella resurfaced and 
non-resurfaced prostheses 2 years after surgery (Johnston et 
all. 2009). An open prospective multicenter study using the 
NexGen  prosthesis  concluded  with  a  recommendation  of 
resurfacing of the patella (Tabutin et al. 2005). In a recent 
study, an expected value decision analysis was used to deter-
mine the best pathway for treatment of the patella during TKA 
(Helmy et al. 2008). Based on data from seven RCTs, primary 
resurfacing of the patella was recommended. 
Few studies make use of the advantages of data available 
from arthroplasty registers, but an 8-year-old study from the 
Swedish Knee Arthroplasty Register showed that resurfacing 
was the best choice of treatment as measured by rate of patient 
satisfaction with the result of the intervention, but this advan-
tage decreased with the length of time that had passed since 
operation (Robertsson et al. 2000).
Possible implications
Our study indicates a need to reconsider the widely accepted 
recommendation  of  primary  resurfacing  of  the  patella.  A 
change in operation procedures towards less use of a patella 
component during primary TKA might be advisable. This will 
probably give the advantages of less extensive operation pro-
cedures with better preservation of the soft tissue of the patella, 
lower risk of revision due to infections, lower risk of patella 
fractures, shorter operation time, and lower cost (Furnes et al. 
2002, Chalidis et al. 2007).
Conclusion
The results of our study indicate that resurfacing of the patella 
has no clinical effect on pain and function after a TKA. The 
differences between the brands investigated were small and 
they were assumed to be of little importance clinically.
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